ACG 2019: Tofacitinib May Not Increase Thromboembolic Risk in Ulcerative Colitis
But findings not conclusive and effort should be made to minimize dose after induction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.